Comparison of biologic porcine secretin, synthetic porcine secretin, and synthetic human secretin in pancreatic function testing

Pancreas

Volumn 27, Issue 3, 2003, Pages 230-234

  Somogyi, Lehel ^b   Ross, Shea O ^b   Cintron, Miriam ^b   Toskes, Phillip P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Bicarbonate; Biologic porcine secretin; Chronic pancreatitis; Synthetic human secretin; Synthetic porcine secretin

Indexed keywords

BICARBONATE; SECRETIN;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; FEMALE; HUMAN; MALE; NONHUMAN; PANCREAS FUNCTION TEST; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SWINE; TACHYCARDIA;

ADULT; AGED; ANIMALS; CHRONIC DISEASE; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC FUNCTION TESTS; PANCREATITIS; SECRETIN; SWINE;

EID: 0141483120     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200310000-00006     Document Type: Article

References (19)

1. Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol (Lond). 1902;28:325-353.
2. Diamond JS, Siegel SA. The secretin test in the diagnosis of pancreatic disease with a report of one hundred thirty tests. Am J Dig Dis. 1940;7:435-442.
3. Hayakawa T, Kondo T, Shibata T, et al. Relationship between pancreatic exocrine function and histological changes in chronic pancreatitis. Am J Gastroenterol. 1992;87:1170-1174.
4. Heij HA, Obertop H, Van Blankenstein M, et al. Relationship between functional and histological changes in chronic pancreatitis. Dig Dis Sci. 1986;31:1009-1013.
5. Walsh TN, Rode J, Theis BA, et al. Minimal change chronic pancreatitis. Gut. 1992;33:1566-1571.
6. DiMagno EP. A perspective on the use of tubeless pancreatic function tests in diagnosis. Gut. 1998;43:2-3.
7. Kitagawa M, Naruse S, Ishiguro H, et al. Evaluating exocrine function tests for diagnosing chronic pancreatitis. Pancreas. 1997;15:402-408.
8. Kataoka K, Yamane Y, Kato M, et al. Diagnosis of chronic pancreatitis using noninvasive tests of exocrine pancreatic function-comparison to duodenal intubation tests. Pancreas. 1997;15:409-415.
9. Horvath K, Stefanatos G, Sokolski KN, et al. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys. 1998;9:9-15.
10. Owley T, Steele E, Corsello C, et al. A double-blind, placebo-controlled trial of secretin for the treatment of autistic disorder. Med Gen Med. 1999; 6:E2.
11. Sandler AD, Sutton KA, DeWeese J, et al. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Eng J Med. 1999;341:1801-1806.
12. Dunn-Geier J, Ho HH, Auersperg E, et al. Effect of secretin on children with autism: a randomized, controlled trial. Dev Med Child Neurol. 2000; 42:796-802.
13. Chez MG, Buchanan CP, Bagan BT, et al. Secretin and autism: a two-part clinical investigation. J Autism Dev Disord. 2000;30:87-94.
14. Jowell PS, Robuck-Mangum G, Mergener K, et al. A double-blind, randomized, dose response study testing the pharmacological efficacy of synthetic porcine secretin. Aliment Pharmacol Ther. 2000;14:1679-1684.
15. Somogyi L, Cintron M, Toskes PP. Synthetic porcine secretin is highly accurate in pancreatic function testing in individuals with chronic pancreatitis. Pancreas. 2000;21:262-265.
16. Lankisch PG, Creutzfeldt W. Effect of synthetic and natural secretin on the function of the exocrine pancreas in man. Digestion. 1981;22:61-65.
17. Hoppe B, Fritsch WP, Scholten T, et al. Comparison of the effects of natural and synthetic secretin on the exocrine secretion of the human pancreas. Z Gastroenterol. 1980;18:625-632.
18. Farooq O, Sturdevant RAL, Isenberg JI. Comparison of synthetic and natural porcine secretins on human pancreatic secretions. Gastroenterology. 1974;66:204-209.
19. Goldschmeidt M, Redfern JS, Feldman M. Effect of propranolol on secretin-induced gastrin release and secretin-induced tachycardia in patients with Zollinger-Ellison syndrome. Aliment Pharmacol Ther. 1990;4:325-331.